JAKARTA. PT Itama Ranoraya Tbk (IRRA) recorded a net profit growth of 104.89% in the first half (1H) of 2020 to Rp 9.63 billion.
In its disclosure published on the Indonesia Stock Exchange (IDX) website, the company stated that it record operating income growth of 29.5% (YoY) to Rp 79.41 billion.
Sales of in-vitro diagnostic products were the biggest contributors to the company's revenue recorded at Rp 78.01 billion, followed by sales of sterile non-electromedic medical devices (Rp 1.40 billion).
Along with the growth in sales, the company also recorded a 39.5% growth in its cost of goods sold to Rp 67.43 billion. (AM/AR)